Results

eNauka >  Rezultati >  Advancing therapy with iGlarLixi versus premix BIAsp 30 in basal insulin-treated type 2 diabetes: Design and baseline characteristics of the SoliMix randomized controlled trial
Naziv: Advancing therapy with iGlarLixi versus premix BIAsp 30 in basal insulin-treated type 2 diabetes: Design and baseline characteristics of the SoliMix randomized controlled trial
Autori: McCrimmon, Rory J.; Al Sifri, Saud; Emral, Rifat; Mohan, Viswanathan; Sauque-Reyna, Leobardo; Trescoli, Carlos; Lalić, Nebojša M. ; Alvarez, Agustina; Demil, Nacima; Coudert, Mathieu;
Shaunik, Alka; Bonnemaire, Mireille; Rosenstock, Julio;
Godina: 2021
Publikacija: Diabetes, obesity & metabolism
ISSN: 1462-8902 Diabetes Obesity and Metabolism Pretraži identifikator
Izdavač: Oxford : Wiley-Blackwell
Tip rezultata: Naučni članak
Kolacija: vol. 23 br. 6 str. 1221-1231
DOI: 10.1111/dom.14354
WoS-ID: 000645097200001
Scopus-ID: 2-s2.0-85103420610
PMID: 33606908
URI: https://enauka.gov.rs/handle/123456789/822844
URL: https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.14354
Projekat: Sanofi, Paris, France
Izvor metapodataka: (Preuzeto iz Nasi u WoS)
M-kategorija: 
21aM21a - Vodeći međunarodni časopis kategorije M21a

29
SCOPUSTM
14
PubMed CentralTM
12
OpenCitations
25
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.